(1R)-1-[5-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]methylsulfanyl]-4-butyl-1,2,4-triazol-3-yl]-N,N-dimethylpropan-1-amine

C20H27BrN6OS — CID 25378230

IUPAC(1R)-1-[5-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]methylsulfanyl]-4-butyl-1,2,4-triazol-3-yl]-N,N-dimethylpropan-1-amine
SMILESCCCCn1c(SCc2nnc(-c3ccc(Br)cc3)o2)nnc1[C@@H](CC)N(C)C
InChIInChI=1S/C20H27BrN6OS/c1-5-7-12-27-18(16(6-2)26(3)4)23-25-20(27)29-13-17-22-24-19(28-17)14-8-10-15(21)11-9-14/h8-11,16H,5-7,12-13H2,1-4H3/t16-/m1/s1
InChIKeyLJKZHWHEIAKBJJ-MRXNPFEDSA-N
MW479.45 g/mol
LogP5.20
Rot. Bonds10

About (1R)-1-[5-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]methylsulfanyl]-4-butyl-1,2,4-triazol-3-yl]-N,N-dimethylpropan-1-amine

(1R)-1-[5-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]methylsulfanyl]-4-butyl-1,2,4-triazol-3-yl]-N,N-dimethylpropan-1-amine (PubChem CID 25378230) has the molecular formula C20H27BrN6OS and a molecular weight of 479.45 g/mol. Its IUPAC name is (1R)-1-[5-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]methylsulfanyl]-4-butyl-1,2,4-triazol-3-yl]-N,N-dimethylpropan-1-amine.

Molecular Properties

Compound Name(1R)-1-[5-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]methylsulfanyl]-4-butyl-1,2,4-triazol-3-yl]-N,N-dimethylpropan-1-amine
PubChem CID25378230
Molecular FormulaC20H27BrN6OS
Molecular Weight479.45 g/mol
Exact Mass478.12
IUPAC Name(1R)-1-[5-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]methylsulfanyl]-4-butyl-1,2,4-triazol-3-yl]-N,N-dimethylpropan-1-amine
SMILESCCCCn1c(SCc2nnc(-c3ccc(Br)cc3)o2)nnc1[C@@H](CC)N(C)C
InChIInChI=1S/C20H27BrN6OS/c1-5-7-12-27-18(16(6-2)26(3)4)23-25-20(27)29-13-17-22-24-19(28-17)14-8-10-15(21)11-9-14/h8-11,16H,5-7,12-13H2,1-4H3/t16-/m1/s1
InChIKeyLJKZHWHEIAKBJJ-MRXNPFEDSA-N
XLogP5.20
TPSA72.87 Ų
H-Bond Donors
H-Bond Acceptors8
Rotatable Bonds10
Heavy Atoms29
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500479.45
LogP ≤ 55.20
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 108

Analyze (1R)-1-[5-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]methylsulfanyl]-4-butyl-1,2,4-triazol-3-yl]-N,N-dimethylpropan-1-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (1R)-1-[5-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]methylsulfanyl]-4-butyl-1,2,4-triazol-3-yl]-N,N-dimethylpropan-1-amine?
The IUPAC name of (1R)-1-[5-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]methylsulfanyl]-4-butyl-1,2,4-triazol-3-yl]-N,N-dimethylpropan-1-amine (CID 25378230) is (1R)-1-[5-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]methylsulfanyl]-4-butyl-1,2,4-triazol-3-yl]-N,N-dimethylpropan-1-amine.
What is the SMILES notation for (1R)-1-[5-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]methylsulfanyl]-4-butyl-1,2,4-triazol-3-yl]-N,N-dimethylpropan-1-amine?
The canonical SMILES for (1R)-1-[5-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]methylsulfanyl]-4-butyl-1,2,4-triazol-3-yl]-N,N-dimethylpropan-1-amine is CCCCn1c(SCc2nnc(-c3ccc(Br)cc3)o2)nnc1[C@@H](CC)N(C)C.
What is the InChIKey of (1R)-1-[5-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]methylsulfanyl]-4-butyl-1,2,4-triazol-3-yl]-N,N-dimethylpropan-1-amine?
The InChIKey is LJKZHWHEIAKBJJ-MRXNPFEDSA-N. The full InChI is InChI=1S/C20H27BrN6OS/c1-5-7-12-27-18(16(6-2)26(3)4)23-25-20(27)29-13-17-22-24-19(28-17)14-8-10-15(21)11-9-14/h8-11,16H,5-7,12-13H2,1-4H3/t16-/m1/s1.
What are the key properties of (1R)-1-[5-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]methylsulfanyl]-4-butyl-1,2,4-triazol-3-yl]-N,N-dimethylpropan-1-amine?
(1R)-1-[5-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]methylsulfanyl]-4-butyl-1,2,4-triazol-3-yl]-N,N-dimethylpropan-1-amine has a molecular weight of 479.45 g/mol, XLogP of 5.20, 10 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (1R)-1-[5-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]methylsulfanyl]-4-butyl-1,2,4-triazol-3-yl]-N,N-dimethylpropan-1-amine is sourced from PubChem (CID 25378230), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).